These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 14025821)

  • 21. Excretion of porphobilinogen and Delta-aminolaevulinic acid in acute porphyria.
    WITH TK
    Lancet; 1961 Aug; 2(7200):485-6. PubMed ID: 13786050
    [No Abstract]   [Full Text] [Related]  

  • 22. [NORMAL VALUES OF THE EXCRETION OF DELTA-AMINOLEVULINIC ACID, PORPHOBILINOGEN AND COPROPORPHYRIN IN THE URINE OF GUINEA PIGS].
    GRABECKI J; OTRZONSEK N; URBANOWICZ H
    Patol Pol; 1965; 16():21-3. PubMed ID: 14348106
    [No Abstract]   [Full Text] [Related]  

  • 23. [Renal delta-aminolevulinic acid excretion in persons not exposed to lead].
    Massmann W
    Zentralbl Arbeitsmed Arbeitsschutz Prophyl Ergonomie; 1982 Jun; 32(6):210-2. PubMed ID: 7113496
    [No Abstract]   [Full Text] [Related]  

  • 24. [delta-Aminolevulinic acid in the serum and relation to its urinary elimination in subjects with lead poisoning].
    CHIESURA P; BRUGNONE F
    Med Lav; 1963 Feb; 54():88-94. PubMed ID: 14020815
    [No Abstract]   [Full Text] [Related]  

  • 25. [Determination of 6-aminolevulinic acid and porphobilinogen in the urine].
    GUTNIAK O; KRAWCZYK I
    Pol Arch Med Wewn; 1962; 32():1517-23. PubMed ID: 13951462
    [No Abstract]   [Full Text] [Related]  

  • 26. The metabolism of 5-aminolaevulinic acid, porphobilinogen, uroporphyrin and coproporphyrin in lead poisoning.
    SANO S; TANABE Y; SUMIYA C
    Acta Sch Med Univ Kioto; 1960; 36():186-90. PubMed ID: 14441536
    [No Abstract]   [Full Text] [Related]  

  • 27. Fluorimetric determination of urinary delta-aminolevulinic acid by high-performance liquid chromatography and post-column derivatization.
    Okayama A
    J Chromatogr; 1988 Apr; 426(2):365-9. PubMed ID: 3392148
    [No Abstract]   [Full Text] [Related]  

  • 28. [A new method for the clinical determination of urinary porphobilinogen and delta-aminolevulinic acid].
    Schmidt M; Eisenburg J
    Fortschr Med; 1977 Mar; 95(10):653-8. PubMed ID: 14874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The occurrence and determination of delta-amino-levulinic acid and porphobilinogen in urine.
    MAUZERALL D; GRANICK S
    J Biol Chem; 1956 Mar; 219(1):435-46. PubMed ID: 13295297
    [No Abstract]   [Full Text] [Related]  

  • 30. PORPHOBILINOGEN AND DELTA-AMINOLEVULINIC ACID EXCRETION IN MULTIPLE SCLEROSIS.
    TAYLOR JD; PAZDER LH; MARKLE V
    Can Med Assoc J; 1965 Jun; 92(26):1342-4. PubMed ID: 14312444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Biological monitoring of workers exposed to lead. Usefulness and limitations of indicators of internal dose and early biological effect].
    Alessio L; Bertazzi PA; Cortona G
    Med Lav; 1978; 69(1):4-25. PubMed ID: 349336
    [No Abstract]   [Full Text] [Related]  

  • 32. Letter: Possible mechanism of the interference of porphobilinogen in the direct determination of urinary delta-aminolevulinic acid.
    Tutor Valcarce JC; Garcia Devesa J; del Rio Anido R
    Clin Chem; 1976 Sep; 22(9):1540-1. PubMed ID: 954202
    [No Abstract]   [Full Text] [Related]  

  • 33. [Studies on patients with polychlorinated biphenyls poisoning. Determination of urinary coproporphyrin, uroporphyrin, delta-aminolevulinic acid, and porphobilinogen (author's transl)].
    Lu FJ; Chang KJ; Lin SC; Tung TC
    Taiwan Yi Xue Hui Za Zhi; 1980 Nov; 79(11):990-5. PubMed ID: 6788895
    [No Abstract]   [Full Text] [Related]  

  • 34. [Automated analysis of Delta-Aminolaevulinic acid in urine (author's transl)].
    Kuhn G
    Int Arch Occup Environ Health; 1977 Oct; 40(1):37-44. PubMed ID: 914374
    [No Abstract]   [Full Text] [Related]  

  • 35. [Determination of delta-aminolevulinic acid in lead poisoning].
    BASIN B
    Arch Mal Prof; 1963; 24():638-44. PubMed ID: 13969845
    [No Abstract]   [Full Text] [Related]  

  • 36. [Correlation of concentrations of gamma aminolevulinic acid and creatinine in the urine (screening test for lead exposure by urinary spot samples)].
    Kikuchi M; Nishima T
    Nihon Eiseigaku Zasshi; 1975 Apr; 30(1):108. PubMed ID: 1169457
    [No Abstract]   [Full Text] [Related]  

  • 37. [Experience with the Grabecki and co-workers method of urinary delta-aminolevulinic acid determination in the prevention of lead intoxication].
    Müller W; Holzapfel G
    Int Arch Arbeitsmed; 1969 Dec; 25(4):287-91. PubMed ID: 5370813
    [No Abstract]   [Full Text] [Related]  

  • 38. Control of lead workers by determination of urinary delta-aminolaevulinic acid.
    Cramér K; Selander S
    Br J Ind Med; 1967 Oct; 24(4):283-8. PubMed ID: 6073085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Use of some indicators of "effect" in subjects exposed to lead].
    Abbritti G
    Med Lav; 1978; 69(1):96-7. PubMed ID: 651778
    [No Abstract]   [Full Text] [Related]  

  • 40. [Significance of urinary delta-aminolevulinic acid determination in the evaluation of individual exposure to lead].
    Sartor F; Rondia D
    Arch Belg Med Soc; 1978 May; 36(5):283-95. PubMed ID: 736553
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.